Taken together, this finding indicates that KS18 plays a dual role at both transcriptional and post-translational levels of Mcl-1 inhibition and this dual mechanism of action contributes to its efficacy in inducing cell death in MM. Here, MCL1 is linked to Miyoshi myopathy.